PKM and neoplasm: Jyotika Jadhav et al. developed a series of ferrocene-based tumor PKM2 modulators, and some of these compounds showed high efficacy and specificity on CAL27 cells, a representative of human oral squamous cell carcinoma (OSCC) [118].